Carna Biosciences, Inc. (TYO:4572)
Japan · Delayed Price · Currency is JPY 223.00
+2.00 (0.90%)
Aug 29, 2025, 12:43 PM JST
Carna Biosciences Market Cap
Carna Biosciences has a market cap or net worth of 4.22 billion as of August 28, 2025. Its market cap has decreased by -35.91% in one year.
Market Cap
4.22B
Enterprise Value
3.18B
Revenue
572.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
223.00
Market Cap Chart
Since March 25, 2008, Carna Biosciences's market cap has decreased from 4.63B to 4.22B, a decrease of -8.75%. That is a compound annual growth rate of -0.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 4.22B | -26.30% |
| Dec 30, 2024 | 5.73B | -35.99% |
| Dec 29, 2023 | 8.95B | 21.11% |
| Dec 30, 2022 | 7.39B | -49.61% |
| Dec 30, 2021 | 14.67B | -2.43% |
| Dec 30, 2020 | 15.03B | -38.91% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 10.50T |
| Takeda Pharmaceutical Company | 6,858.72B |
| Daiichi Sankyo Company | 6,600.46B |
| HOYA Corporation | 6,584.48B |
| Otsuka Holdings | 4,138.44B |
| Terumo | 3,947.98B |
| Astellas Pharma | 2,892.25B |
| Shionogi & | 2,172.48B |